J Genet Med.
2012 Jun;9(1):25-30. 10.5734/JGM.2012.9.1.25.
Risk Reducing Surgery in Carriers with Double Heterozygosity for BRCA1 and BRCA2 Mutations
- Affiliations
-
- 1Department of Surgery, Ajou University School of Medicine, Suwon, Korea. ideakims@gmail.com
- 2Department of Hematology - Oncology, Ajou University School of Medicine, Suwon, Korea.
- 3Department of Radiology, Ajou University School of Medicine, Suwon, Korea.
- 4Department of Pathology, Ajou University School of Medicine, Suwon, Korea.
- 5Department of Radiation Oncology, Ajou University School of Medicine, Suwon, Korea.
- 6Department of Plastic and Reconstructive Surgery, Ajou University School of Medicine, Suwon, Korea.
- 7Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea.
- KMID: 2055566
- DOI: http://doi.org/10.5734/JGM.2012.9.1.25
Abstract
- Among the treatment options for BRCA mutation carriers, risk reducing surgery is the most effective. However, this procedure has been rarely performed in Korea. Interestingly, our case showed double heterozygosity for BRCA1 and BRCA2 mutations. The patient was diagnosed with left renal cancer and left breast cancer at 45-years-of-age, 4 years before risk reducing surgery. The patient received left radical nephrectomy and left partial mastectomy with axillary lymph node dissection. After pretest counseling, the patient underwent genetic testing that identified BRCA1 and BRCA2 mutations. After post-test counseling, the patient decided on intensive surveillance. At 49-years-of-age, the patient was newly diagnosed with contralateral breast cancer. Treatment options were discussed once again. We performed bilateral total mastectomy with immediate reconstruction and prophylactic bilateral salpingo-oophorectomy after multidisciplinary discussion. The patient has been satisfied with the results of surgery. We think this procedure is a recommendable treatment option for BRCA mutation carriers.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Frequency of BRCA1 and BRCA2 Germline Mutations Detected by Protein Truncation Test and Cumulative Risks of Breast and Ovarian Cancer among Mutation Carriers in Japanese Breast Cancer Families
- Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy
- Basic knowledge for counseling patients undergoing risk-reducing salpingo-oophorectomy
- Novel Germline Mutations of BRCA1 and BRCA2 in Korean Familial Breast Cancer Patients
- Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients
